Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
about
Medical treatments in the short term management of reflux oesophagitisShort-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseMedical treatments in the short term management of reflux oesophagitisClinical practice. Gastroesophageal reflux diseaseThe role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitorsEsomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.Gastroesophageal reflux disease: medical or surgical treatment?Heartburn treatment in primary care: randomised, double blind study for 8 weeksNonerosive Reflux Disease (NERD) - An Update.Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis.Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.Definitions of reflux disease and its separation from dyspepsiaShort-term treatment of gastroesophageal reflux disease.Does deep sedation impact the results of 48 hours catheterless pH testing?Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.Risks, precipitants and clinical presentation of gastro-oesophageal reflux disease at the Kilimanjaro Christian medical centre in Tanzania [corrected]Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritisSymptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputsAssessment of reflux symptom severity: methodological options and their attributes.Best practice in symptom assessment: a review.A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Current trends in the management of gastroesophageal reflux disease: a review.Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Treatment of uncomplicated reflux diseaseDaytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.An update on the available treatments for non-erosive reflux disease.Long-term management of GERD in the elderly with pantoprazole.Current advances in the diagnosis and treatment of nonerosive reflux disease.Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist.Acid peptic diseases: pharmacological approach to treatment.NERD: an umbrella term including heterogeneous subpopulations.Gastro-oesophageal reflux. Part 2: medical treatment.
P2860
Q24234225-DA110375-CFE7-4900-A18C-22908B4079AEQ24236493-BC05036B-CE67-4575-B1DA-7021EB09AD7CQ24245220-13A4E28B-3114-4FB9-90AD-E6E6D6BF1358Q24596151-06EB8F24-4B44-44BC-91B0-E9A85AF530CCQ26866168-B4263ECF-EA13-4D60-A22B-9937F63B35A5Q32026591-882823ED-E80A-4119-8901-6438813283C4Q33580756-FF9CA0C0-0441-4A14-B29E-AB81A8F9C150Q33648493-6261845B-FDBA-4165-AE9A-1FFC2EEFBB13Q33890423-54DE5F13-0C4F-4E4E-83CD-868FAA581625Q33898666-BB7EF3C7-99DC-48B1-88FB-6DAD0DC04992Q33952311-D5A089AF-BA63-4800-B062-F212FE0C455FQ33954796-F5311474-2B73-4C91-88DC-D9DE232CD35AQ34181922-B1F26C70-C0C0-491C-B397-5D8884F00C10Q34266222-C2D99AC7-C6AA-4DA2-A254-C4E43983E0B2Q34541695-0359F028-FF26-4295-9721-45F4859079A9Q34601043-C4E2947C-8357-4216-A0C8-11435BB0EE05Q34742191-46D03D5F-D30A-43D8-AA2D-1C35F4A88BB8Q34744849-B233111F-50C3-4704-BB34-0C25B6AECE35Q34786709-92EB92FE-22F2-4434-958E-79E070E79BD0Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2Q35123734-32556228-183E-42F8-9034-F25CB4AB08ADQ35164691-7D46F3EF-0D0F-4E34-B602-FDFEA4342F7FQ35609697-52632F28-BE58-4112-B1DC-3F003719FF75Q35716289-A32B6712-8AD1-40EE-9C14-40DDFEE5DCFAQ35745029-699D5671-0AAC-4987-93B1-17095A7B80BEQ35745038-C235C81E-62B3-431B-9CCA-005829F5E51FQ35745054-6758F017-C39A-4B9B-9A99-DB0A0BA5B886Q35745058-B985E0BA-AE7B-4E83-BBD6-7D23B9A66C3BQ36107247-8537B9C0-9BA9-4B6A-AABB-E63D94F785FAQ36117874-7ECD2022-165B-464D-8D28-105E4EEE6F81Q36204260-2F32555D-5AA7-4DAD-A91C-4072925DBA1BQ36212184-1C157B4B-A599-4DA2-8E89-40DC79A3D7EEQ36349598-1FBDA0D4-52F8-4693-AB67-BFB99040E34CQ37017283-A55F3885-689D-4481-98CC-B9AC6927BD8FQ37051858-9A7AC69B-A266-4D0D-B994-B46A86F90845Q37234008-3835AD4E-E2A1-4161-A9B4-74AC6792B09BQ37532133-C4D4B376-EC43-4B1F-801D-5242BEC18645Q37913063-7FB37488-1A86-4689-AB20-1BD043B3173CQ38092939-50C3201C-946F-4DCA-9A7E-26D8A5EC839DQ38094883-E9B86CDF-2226-461C-8E88-7AACDD6739AB
P2860
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Omeprazole 10 milligrams once ...... x disease in general practice.
@en
Omeprazole 10 milligrams once ...... x disease in general practice.
@nl
type
label
Omeprazole 10 milligrams once ...... x disease in general practice.
@en
Omeprazole 10 milligrams once ...... x disease in general practice.
@nl
prefLabel
Omeprazole 10 milligrams once ...... x disease in general practice.
@en
Omeprazole 10 milligrams once ...... x disease in general practice.
@nl
P2093
P2860
P1476
Omeprazole 10 milligrams once ...... x disease in general practice.
@en
P2093
P2860
P304
P356
10.3109/00365529709011211
P577
1997-10-01T00:00:00Z